Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Wilkinson

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
The Lancet. Neurology|October 23, 2021
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trialPatrick Gavin Kehoe, Nicholas Turner, Beth Howden, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 14, 2017
Quantification of Lung PET Images: Challenges and OpportunitiesDelphine L Chen, Joseph Cheriyan, Edwin R Chilvers, et al.
Trials|December 6, 2018
Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trialAngelos G Kolias, Ellie Edlmann, Eric P Thelin, et al.
Trials|March 20, 2019
Correction to: Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trialAngelos G Kolias, Ellie Edlmann, Eric P Thelin, et al.
Neuroimage|January 15, 2019
Quantifying normal human brain metabolism using hyperpolarized [1-<sup>13</sup>C]pyruvate and magnetic resonance imagingJames T Grist, Mary A McLean, Frank Riemer, et al.
Heart (British Cardiac Society)|September 24, 2024
Advancing the access to cardiovascular diagnosis and treatment among women with cardiovascular disease: a joint British Cardiovascular Societies' consensus documentUpasana Tayal, Graziella Pompei, Ian Wilkinson, et al.
Radiology. Imaging Cancer|July 15, 2022
Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-<sup>13</sup>C]Pyruvate Demonstrates Heterogeneity in Lactate Labeling: A Proof of Principle StudyFulvio Zaccagna, Mary A McLean, James T Grist, et al.
The New England Journal of Medicine|December 16, 2020
Trial of Dexamethasone for Chronic Subdural HematomaPeter J Hutchinson, Ellie Edlmann, Diederik Bulters, et al.
Scientific Reports|April 12, 2019
Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phaseEllie Edlmann, Eric P Thelin, Karen Caldwell, et al.
Health Technology Assessment (Winchester, England)|March 21, 2024
A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)Peter J Hutchinson, Ellie Edlmann, John G Hanrahan, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
The Lancet. Neurology|October 23, 2021
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trialPatrick Gavin Kehoe, Nicholas Turner, Beth Howden, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 14, 2017
Quantification of Lung PET Images: Challenges and OpportunitiesDelphine L Chen, Joseph Cheriyan, Edwin R Chilvers, et al.
Trials|December 6, 2018
Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trialAngelos G Kolias, Ellie Edlmann, Eric P Thelin, et al.
Trials|March 20, 2019
Correction to: Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trialAngelos G Kolias, Ellie Edlmann, Eric P Thelin, et al.
Neuroimage|January 15, 2019
Quantifying normal human brain metabolism using hyperpolarized [1-<sup>13</sup>C]pyruvate and magnetic resonance imagingJames T Grist, Mary A McLean, Frank Riemer, et al.
Heart (British Cardiac Society)|September 24, 2024
Advancing the access to cardiovascular diagnosis and treatment among women with cardiovascular disease: a joint British Cardiovascular Societies' consensus documentUpasana Tayal, Graziella Pompei, Ian Wilkinson, et al.
Radiology. Imaging Cancer|July 15, 2022
Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-<sup>13</sup>C]Pyruvate Demonstrates Heterogeneity in Lactate Labeling: A Proof of Principle StudyFulvio Zaccagna, Mary A McLean, James T Grist, et al.
The New England Journal of Medicine|December 16, 2020
Trial of Dexamethasone for Chronic Subdural HematomaPeter J Hutchinson, Ellie Edlmann, Diederik Bulters, et al.
Scientific Reports|April 12, 2019
Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phaseEllie Edlmann, Eric P Thelin, Karen Caldwell, et al.
Health Technology Assessment (Winchester, England)|March 21, 2024
A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)Peter J Hutchinson, Ellie Edlmann, John G Hanrahan, et al.
Pageof 8